Xpreza 300mg Tablet
Marketer
Natco Pharma Ltd
Salt Composition
Azacitidine (300mg)
Overview Xpreza 300mg Tablet
Azacitidine 300mg tablets are indicated in the management of specific hematologic malignancies. They're approved for adult patients across all Myelodysplastic Syndrome (MDS) subtypes. Off-label uses may be determined by a physician. Azacitidine 300mg tablets can be administered with or without food, but consistent daily timing is recommended. Dosage and frequency are individualized by your doctor based on your condition and may be adjusted. Strict adherence to the prescribed regimen is crucial; incorrect usage or overdose can lead to severe adverse effects. Therapeutic benefits might not be evident for several weeks or months; discontinuation should only occur under medical supervision. Commonly reported adverse reactions include emesis, asthenia, nausea, and pyrexia. Report any concerning symptoms to your physician; mitigating strategies may be available. Vaccination during treatment requires prior physician consultation. Regular monitoring of blood counts, along with cardiac, hepatic, and renal function, is mandatory. Pre-treatment disclosure of any pre-existing hepatic or renal impairment, or concurrent use of anti-infective agents, is vital. Potential drug interactions are significant; comprehensive medication disclosure to your physician is essential. This medication is contraindicated during gestation and lactation.
Primary Ingredients of Xpreza 300mg Tablet
No text was provided to rewrite.
Uses of Xpreza 300mg Tablet
Myelodysplastic syndrome: Hematological malignancy therapies
Major Benefits of Xpreza 300mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment schedule. Ingest the 300mg Xpreza tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable; however, consistent daily timing is recommended.
Common Side effects of Xpreza 300mg Tablet:
- Vomiting
- Weakness
- Nausea
- Decreased potassium level in blood
- Bruise
- Fever
- Chills
- Diarrhea
- Constipation
How to use Xpreza 300mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the 300mg Xpreza tablet whole; avoid chewing, crushing, or fracturing it. While consumption with or without food is acceptable, consistent daily timing is recommended.
How Xpreza 300mg Tablet works:
Xpreza 300mg tablets are used in the treatment of leukemia. Their anticancer mechanism disrupts the genetic replication (DNA and RNA) within leukemic cells, leading to cell death and facilitating healthy development of new blood cells within the bone marrow.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Xpreza 300mg Tablet may be unsafe; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Xpreza 300mg tablets during pregnancy poses a confirmed risk to the fetus and is therefore inadvisable. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known dangers. Always seek medical advice.
Breast feedingUNSAFE
Lactation is contraindicated with Xpreza 300mg tablets due to potential infant toxicity.
DrivingUNSAFE
Driving ability may be impaired by side effects, including fatigue, associated with Xpreza 300mg Tablets.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Xpreza 300mg tablets. Dosage modification may be necessary; physician consultation is advised.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Xpreza 300mg tablets, as dose modification may be necessary. Medical advice is recommended. Xpreza 300mg tablets are contraindicated for patients exhibiting advanced hepatocellular carcinoma.
What if you forget to take Xpreza 300mg Tablet :
NA
Facts to Know About Xpreza 300mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Pyrimidine Nucleoside Analog |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Behavior Class | Metabolic inhibitors |
3,018 People bought this recently